1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLCNeoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasmNot yet recruitingPhase 22026-04-29NCT07549061